Assessment of myocardial viability by MRI

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 418-422

  Bax, J J ^a   De Roos, A ^a   Van Der Wall, E E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dobutamine stress testing; Magnetic resonance imaging; Myocardial viability; Nuclear imaging

Indexed keywords

CONTRAST MEDIUM; DOBUTAMINE;

ACUTE HEART INFARCTION; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EXERCISE TEST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

CARDIOTONIC AGENTS; CONTRAST MEDIA; DOBUTAMINE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; TISSUE SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032828616     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<418::AID-JMRI25>3.0.CO;2-C     Document Type: Article

References (46)

1. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72(suppl V):V-123-V-135.
2. Bonow RO, Dilsizian V. Assessing viable myocardium with thallium-201. Am J Cardiol 1992;70:10E-17E.
3. Bax JJ, Van Eck-Smit BLF, Van der Wall EE. Assessment of tissue viability: clinical demand and problems. Eur Heart J 1998; 19:847-858.
4. Rahimtoola SH. Importance of diagnosing hibernating myocardium: how and in whom? J Am Coll Cardiol 1997;30:1701-1706.
5. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
6. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-115.
7. Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;4:785-795.
8. Di Carli MF. Predicting improved function after myocardial revascularization. Curr Opin Cardiol 1998;13:415-424.
9. Mickleborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92(suppl II):II-73-II-79.
10. 201T1 for risk stratification after myocardial infarction and thrombolysis. Circulation 1997;96:2758-2761.
11. Bax JJ, Wijns W, Cornel JH, et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-1460.
12. Van der Wall EE, Vliegen HW, De Roos A, Bruschke AVG. Magnetic resonance imaging in coronary artery disease. Circulation 1995;92: 2723-2739.
13. Van der Wall EE, Bax JJ. Current clinical relevance of cardiovascular magnetic resonance and its relationship to nuclear cardiology. J Nucl Cardiol 1999; in press.
14. Higgins CB. Prediction of myocardial viability by MRI. Circulation 1999;99:727-729
15. McNamara MT, Higgins CB. Magnetic resonance imaging of chronic myocardial infarcts in man. AJR 1986;146:315-320.
16. 201T1 in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992;86:1125-1137.
17. Sechtem U, Voth E, Baer F, et al. Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques. Int J Card Imaging 1993;9:31-40.
18. 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. Eur Heart J 1994;15:97-107.
19. 18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of 7esidual myocardial viability. Circulation 1995;91:1006-1015.
20. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-1048.
21. Dendale P, Franken PR, Holman E, et al. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 1998;82:375-377.
22. Dendale P, Franken PR, Waldman, et al. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J 1995;130:134-140.
23. Geskin G, Kramer CM, Rogers WJ, et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98:217-223.
24. Sayad DE, Willett DL, Hundley G, Grayburn PA, Peshock RM. Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. Am J Cardiol 1998;82:1149-1151.
25. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high dose dobutamine stress MRI. Comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770.
26. Van Rugge FP, Van der Wall EE, De Roos A, Bruschke AVG. Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease. J Am Coll Cardiol 1993;22:431-439.
27. Van Rugge FP, Van der Wall EE, Spanjersberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coroanry artery disease: quantitative wall motion analysis using a modification of the centerline method. Circulation 1994;90:127-138.
28. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992;70:34-40.
29. Baer FM, Voth E, LaRosee K, et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996;78:415-419.
30. Zoghbi WA, Barasch E. Dobutamine MRI: a serious contender in pharmacological stress imaging? Circulation 1999;99:730-732
31. Higgins CB, Saeed M, Wendland MF, et al. Contrast-media for cardiothoracic MR imaging. J Magn Reson Imaging 1993;3:265-276.
32. De Roos A, Doornbos J, Van der Wall EEm, Van Voorthuisen AE. MR imaging of acute myocardial infarction: value of Gd-DTPA. AJR 1988;150:531-534.
33. De Roos A, Van Rossum AC, Van der Wall EE, et al. Reperfused and nonreperfused myocardial infarction: Ddagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989;172:717-720.
34. Saeed M, Wendland MF, Tomei E, et al. Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging. Radiology 1989;173:763-767.
35. Eichenberger AC, Schuiki E, Kochli VD, et al. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging 1994;4:425-431.
36. Judd RM, Lugo-Olivieri CH, Aral M, et al. Physiological basis of myocardial contrast-enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92: 1902-1910.
37. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first-pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29:485-497.
38. Saeed M, Wendland MF, Yu KK, et al. Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused Infarctions. Circulation 1994;90:1492-1501.
39. Saeed M, Wendland M, Takehara Y, Masui T, Higgins CB. Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology 1992;182:675-683.
40. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997;30:1086-1094.
41. Kim RJ, Chen EL, Lima JAC, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast-enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94:3318-3326.
42. Kaul S. Myocardial contrast echocardiography. 15 Years of research and development. Circulation 1997;96:3745-3760.
43. Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998;32:1756-1764.
44. Rogers WJ Jr, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999;99:744-750.
45. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.
46. Klow NE, Smith HJ, Gullestad L, Endresen K. Outcome of bypass surgery in patients with chronic ischemic left ventricular dysfunction. Predictive value of MR imaging. Acta Radiol 1997;38:76-82.